Most Recent

image: An Offensive Playbook

An Offensive Playbook

By | February 1, 2014

Developing nonaddictive drugs to combat pain

0 Comments

image: Contributors

Contributors

By | February 1, 2014

Meet some of the people featured in the February 2014 issue of The Scientist.

0 Comments

image: Meiosis Maven

Meiosis Maven

By | February 1, 2014

Fueled by her love of visual data and addicted to chromosomes, Abby Dernburg continues to study how homologous chromosomes find each other during gamete formation.

1 Comment

image: On Race and Medicine

On Race and Medicine

By | February 1, 2014

Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.

2 Comments

image: Unmasking Secret Identities

Unmasking Secret Identities

By | February 1, 2014

A tour of techniques for measuring DNA hydroxymethylation

2 Comments

image: Pain and Progress

Pain and Progress

By | February 1, 2014

Is it possible to make a nonaddictive opioid painkiller?

1 Comment

image: Syphilis: Then and Now

Syphilis: Then and Now

By , , and | February 1, 2014

Researchers are zeroing in on the origin of syphilis and related diseases, which continue to plague the human population some 500 years after the first documented case.

12 Comments

image: Bacteria by Design

Bacteria by Design

By | January 30, 2014

A survey of bacteria in a University of Oregon building reveals that architecture influences the indoor microbiome.

0 Comments

image: NIH Tackles Irreproducibility

NIH Tackles Irreproducibility

By | January 28, 2014

The federal agency speaks out about how to improve the quality of scientific research.

5 Comments

image: <em>The Scientist</em> on The Pulse #3

The Scientist on The Pulse #3

By | January 28, 2014

Kerry Grens chats about ancient tooth decay, asthma, and fat cells.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS